Federated Hermes
SYRS

Federated Hermes’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Federated Hermes’s Portfolio SYRS Stock Details SYRS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$4.37K Sell
2022
Q3 		$154K Buy
2022
Q2 		$230K Sell
2022
Q1 		$286K Buy
2021
Q4 		$538K Buy
2020
Q4 		– Sell
2020
Q3 		$416K Buy